Aralez Pharmaceuticals (TSE:ARZ) will be posting its quarterly earnings results before the market opens on Tuesday, March 13th. Analysts expect Aralez Pharmaceuticals to post earnings of C($0.43) per share for the quarter.
Shares of Aralez Pharmaceuticals (TSE:ARZ) opened at C$2.57 on Monday. Aralez Pharmaceuticals has a twelve month low of C$1.20 and a twelve month high of C$5.00. The stock has a market capitalization of $133.10 and a PE ratio of -1.53.
Separately, HC Wainwright reiterated a “buy” rating on shares of Aralez Pharmaceuticals in a report on Monday, February 5th.
Aralez Pharmaceuticals Company Profile
Aralez Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company’s products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G.
Receive News & Ratings for Aralez Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aralez Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.